diagnostic criteria for BIMS, 2) estimate its incidence, prognostic impact and population attributable risk fraction with respect to 30-day mortality and 3) develop and validate a clinical prediction guide to estimate patient-specific risk of BIMS. Figure 1 summarizes the flow of participants through the study. Figure 2 summarizes the methods described in this protocol. We will use Stata/MP version 13.1 (StataCorp) and R version 3.3 (R Development Core Team) with the rms package 8 for all analyses.
Methods

Study design
We will analyze data from the VISION study, a prospective international cohort study that included 16 079 patients from 12 centres in 8 countries (throughout North and South America, Australia, Asia and Europe) recruited from August 2007 to January 2011 (ClinicalTrials.gov NCT00512109). VISION enrolment and data collection have been described in previous
Patients who fulfilled VISION study eligibility criteria n = 23 693
Screened in time to fulfill eligibility criteria n = 22 609
Enrolled in VISION n = 16 079
Not identified in time to be enrolled n = 1084 (4.6%)
Not enrolled n = 6530 (28.9%)
• Did not consent n = 5262
• Unable to obtain consent due to cognitive impairment n = 251 • Surgeon did not approve patient participation n = 134 • Other reason n = 883
We will exclude 334 patients (5.7%) with missing data for MINS who experienced bleeding because they did not have a troponin assay measured after surgery or the results were reported as < 0.04, < 0.03 or < 0.02 instead of the absolute value. Among the 5476 remaining patients, we will impute data for the 165 (3.0%) with missing data for preoperative hemoglobin level (n = 34), active cancer (n = 1) and/or postoperative hemoglobin nadir (n = 134)
After removing the 970 patients (6.0%) with missing data for MINS from the full cohort of 16 079 patients, we will impute data for 515 (3.4%) of the 15 109 remaining patients with missing data for preoperative hemoglobin level (n = 384), active cancer (n = 1) and/or postoperative hemoglobin nadir (n = 134)
We will impute data for 1375 patients (8.6%): preoperative serum creatinine in patients not receiving dialysis (n = 1133), preoperative hemoglobin level (n = 402), postoperative hemoglobin nadir (n = 149), requirement of assistance with activities of daily living (n = 3), active cancer (n = 1), preoperative dialysis (n = 1), history of hypertension (n = 1), emergent surgery (n = 1) and/or endoscopic or open surgical technique (n = 3)
Objective 1
Patients who experienced a bleeding event and will be included in analysis to identify diagnostic criteria for BIMS n = 5476
Objective 2 Patients included in analyses
to estimate prognostic importance of BIMS n = 15 109 Age, sex, preoperative hemoglobin level, sex*preoperative hemoglobin level interaction, estimated glomerular filtration rate, assistance with activities of daily living, recent high-risk coronary artery disease, history of congestive heart failure, history of stroke, history of peripheral vascular disease, history of chronic obstructive pulmonary disease, history of hypertension, active cancer, urgent/emergent surgery, thoracic aorta reconstructive vascular operations, aortoiliac reconstructive vascular surgery, peripheral vascular reconstruction without aortic cross-clamping, extracranial cerebrovascular surgery, endovascular abdominal aortic aneurysm repair, complex visceral resection general surgery, partial or total colectomy or stomach surgery, other intraabdominal surgery, major head and neck resection for nonthyroid tumour, pneumonectomy, lobectomy, other thoracic operations, visceral urologic or gynecologic resection, cytoreductive surgery, hysterectomy, radical hysterectomy, radical prostatectomy, transurethral prostatectomy, major hip or pelvic surgery, internal fixation of femur, knee arthroplasty, above-knee amputation, lower leg amputation (amputation below knee but above foot), craniotomy, major spine surgery involving multiple levels of spine, low-risk surgery, open surgical technique interview was conducted with the participant or his or her caregiver 30 days after surgery. If the interview indicated the occurrence of an outcome, the primary care physician was contacted to obtain further documentation. Data monitoring involved central data consistency checks, statistical monitoring and on-site monitoring for all centres. For on-site monitoring, the central coordinator randomly selected participants with and without a perioperative complication, and an on-site monitor then audited the participant's medical records and all supporting documents.
Sample size and completeness of study data
We completed 30-day follow-up for 16 026 (99.7%) of 16 079 patients; the remaining 53 patients did not die within 30 days of surgery, and their data were censored at the time of hospital discharge. The protocol is divided into 3 objectives to be addressed sequentially in the analysis. The sample size and missing data are given separately for each objective in Figure 1 . Where specified, we will impute missing data using single stochastic conditional imputation with predictive mean matching 12 for continuous variables and augmented logistic regression 13 for binary variables, both with fully conditional specification.
14 Box 1 lists the variables to be included in the imputation model. Single stochastic imputation is much more practical for our analysis than multiple imputation, and with few missing data, its drawback -slightly more narrow confidence intervals -will be negligible. 15 Pertinent cohort characteristics are shown in Appendix 1, Supplementary 
Objective 1: establish diagnostic criteria for BIMS
We will restrict the analysis for objective 1 to 5476 patients who experienced a bleeding event to better protect against residual confounding and time-dependent biases. 16 Of the 5476, 167 died within 30 days of surgery. In the VISION study, bleeding was defined broadly to avoid missing prognostically important bleeding events. The definition included all bleeding that resulted in a decrease in hemoglobin concentration of at least 30 g/L, led to a transfusion of blood products or reoperation, or was thought to be the immediate cause of death. If a patient experienced more than 1 bleeding episode during the first 30 days after surgery, we will evaluate only the first episode in all analyses.
The diagnostic criteria for BIMS should identify, among people who experience a bleeding event, as many patients as possible who will die as a consequence of the bleeding within 30 days of surgery and should exclude as many patients as possible who will not die within this period.
We will consider 5 candidate features for inclusion in the diagnostic criteria, in the following order: 1) reoperation for reasons of bleeding, 2) number of units of erythrocytes transfused, 3) the lowest (nadir) postoperative hemoglobin concentration associated with the bleeding, 4) the absolute decrease in hemoglobin concentration from the preoperative value and 5) the relative decrease in hemoglobin concentration from the preoperative value. The features that are the least subjective and easiest to ascertain will be tested first, to ensure that they have a greater chance of becoming part of the BIMS diagnostic criteria compared to less practical correlated candidate features that are similarly associated with mortality. In the VISION study, bleeding was suspected by the clinical team to be the direct cause of death in some patients; this feature will be included in the diagnostic criteria without statistical testing.
We will model the association between 30-day mortality and candidate BIMS criteria using shared (by study centre) frailty multivariable Cox proportional hazards regression models adjusted for preoperative patient characteristics, surgical factors (type and timing of surgery) and other postoperative complications (Table 1) . We selected these adjustment variables on the basis of previous VISION work that identified variables independently associated with death among all patients, with the assumption that the same factors are associated with death in patients who have experienced a bleeding event. 10 We will adjust for patients' requirement of assistance with activities of daily living because functional status has been associated with death in prior studies. [17] [18] [19] We will also adjust for postoperative complications including sepsis, pulmonary embolism, stroke and myocardial injury after noncardiac surgery (MINS) 10 that occurred on a day before the day of a bleeding event, but not those that occurred on the same day or in the days after the bleeding event because BIMS may cause these complications directly (e.g., MINS due to supply-demand mismatch from a low hemoglobin concentration) or indirectly (e.g., pulmonary embolism due to BIMS that resulted in the withdrawal of anticoagulant treatment; sepsis through prolongation of hospital stay and exposure to additional interventions). Adjusting for complications that BIMS may have caused would underestimate the association between a candidate feature and death. 20 Figure 3 summarizes the algorithm for selecting diagnostic criteria for BIMS. This is an iterative process that begins with a baseline model in which the explanatory variables include only the adjustment variables. Candidate features are added to the baseline model, 1 at a time, in the order described in Table 1 . We will test the statistical significance of the first feature (adjusted for the other variables in the model) using a likelihood ratio test. If this test produces a p value ≥ 0.05, we will consider the candidate feature not to be an independent predictor of death, and it will no longer be considered for inclusion in the criteria. The next candidate feature will replace it and will be tested in the same way. If the test produces a p value < 0.05, the candidate feature will be considered a proven independent predictor of death and will be retained in the model. When subsequent candidate features are tested, they will be compared with the model that contains alreadyproven features and the adjustment variables.
To simplify integration of continuous variables (e.g., number of units of erythrocytes transfused) into the diagnostic criteria, these variables will be dichotomized at thresholds according to Table 1 , and a dichotomous version representing each threshold will be tested in the model. We will select the threshold that returns the highest χ 2 statistic from the likelihood ratio test for inclusion in the diagnostic criteria, as long
Box 1 (part 1 of 2): Variables included in imputation model
Age, sex, age-by-sex interaction, preoperative weight, height, preoperative serum creatinine level, preoperative hemoglobin concentration, active cancer, preoperative dialysis, required assistance with activities of daily living preoperatively, endoscopic surgical technique, open surgical technique, duration of surgery, history of chronic obstructive pulmonary disease, history of coronary artery disease (not recent high-risk coronary artery disease), history of recent high-risk coronary artery disease, history of diabetes not requiring insulin preoperatively, history of diabetes requiring insulin preoperatively, history of congestive heart failure, history of transient ischemic attack, history of stroke, history of hypertension, peripheral vascular disease, any use of acetylsalicylic acid within 7 d before surgery, any cyclooxygenase-2 inhibitor use within 7 d before surgery, any use of other nonsteroidal anti-inflammatory medication within 7 d before surgery, any use of angiotensin II receptor blocker or angiotensin-converting-enzyme inhibitor within 7 d before surgery, any β-blocker use within 7 d before surgery, any oral anticoagulant treatment within 7 d before surgery, any prophylactic subcutaneous treatment with an antithrombotic agent within 7 d before surgery, any subcutaneous or intravenous treatment with a therapeutic antithrombotic agent within 7 d before surgery, any clopidogrel or ticlopidine use within 7 d before surgery, any statin use within 7 d before surgery, any α 2 agonist use within 7 d before surgery, any use of a rate-controlling calcium-channel blocker
Definitions Preoperative variables
• Age: Patient's age in years, calculated as the difference between birthdate and date of surgery and rounded down to nearest year.
• Preoperative hemoglobin level: Latest available routinely measured preoperative hemoglobin value.
• Preoperative estimated glomerular filtration rate: Calculated with the Chronic Kidney Disease Epidemiology Collaboration equation; latest available routinely measured preoperative serum creatinine value.
• Requires assistance with activities of daily living: Patient requires assistance from another person with any of the following activities: dressing, eating, ambulating, toileting or hygiene. If a patient has incurred an acute injury leading to the need for surgery (e.g., hip fracture), the assessment for requirement of help for activities of daily living is based on his or her condition before the acute injury.
• Congestive heart failure: Physician diagnosis of a current or prior episode of congestive heart failure or prior radiographic evidence of vascular redistribution, interstitial pulmonary edema or frank alveolar pulmonary edema.
• Recent high-risk coronary artery disease: Diagnosis ≤ 6 mo before noncardiac surgery of myocardial infarction, acute coronary syndrome, Canadian Cardiovascular Society grade III angina (angina occurring with level walking of 1-2 blocks or climbing 1 flight of stairs at a normal pace) or grade IV angina (inability to perform any physical activity without the development of angina).
• Cerebral vascular event: Physician diagnosis of stroke, computed tomography (CT) or magnetic resonance imaging evidence of a prior stroke, or physician diagnosis of a prior transient ischemic attack.
• Peripheral vascular disease: Current or prior history of physician-diagnosed intermittent claudication, vascular surgery for atherosclerotic disease, an ankle-arm systolic blood pressure ratio ≤ 0.90 in either leg at rest, or angiographic or Doppler study showing ≥ 70% stenosis in a noncardiac artery.
• Chronic obstructive pulmonary disease (COPD): If the chart or a physician had ever indicated that a patient has chronic bronchitis, we accepted this as a patient's having COPD. If there was no mention of this but the patient reported that he or she had daily production of sputum for at least 3 mo in 2 consecutive yr, the patient was classified as having COPD. Likewise, if a physician had ever indicated that a patient had emphysema or if a patient's pulmonary function tests stated fixed or irreversible airflow limitation and/or emphysema, the patient was classified as having COPD.
• Active cancer: Patient had a current diagnosis of cancer or was undergoing surgery for cancer.
Surgical variables
If the patient underwent more than 1 operation, all operations performed were included.
• Major vascular surgery 
Box 1 (part 2 of 2): Variables included in imputation model
• Major general surgery
Complex visceral resection (surgery involving the liver, esophagus, pancreas or multiple organs)
2. Partial or total colectomy or stomach surgery 3. Other intra-abdominal surgery (gallbladder, appendix, adrenal gland, spleen, regional lymph node dissection)
4. Major head and neck resection for nonthyroid tumour.
• Thoracic surgery 1. Pneumonectomy 2. Lobectomy 3. Other thoracic surgical procedures (wedge resection of lung, resection of mediastinal tumour, major chest wall resection).
• Major urologic or gynecologic surgery • Major neurosurgery 1. Craniotomy 2. Major spine surgery: Surgery involving multiple levels of the spine.
• Low-risk surgery: Any parathyroid, thyroid, breast, hernia or local anorectal procedure, oopherectomy, salpingectomy, endometrial ablation, peripheral nerve surgery, ophthalmologic surgery, ear/nose/throat surgery, vertebral disc surgery, hand surgery, cosmetic surgery, arteriovenous access surgery for dialysis, other procedures.
• Urgent or emergency surgical procedures: Procedures performed within 72 hours of acute event that led to the need for surgery.
• Duration of surgery: Time elapsed, in minutes, between when the surgeon began the procedure and when he or she closed the wound.
• Surgical techniques 
Postoperative complications
• Bleeding: Defined as bleeding that results in a decrease in hemoglobin level of 30 g/L (3 g/dL) or more, leads to transfusion or reoperation, or is thought to be the cause of death.
• Myocardial injury after noncardiac surgery: Any peak cardiac troponin T level ≥ 0.03 ng/mL resulting from myocardial ischemia (i.e., without evidence of a nonischemic cause) that occurred with the first 30 d after surgery. 10 We measured non-high-sensitivity cardiac troponin T levels using a fourth-generation Elecsys assay (Roche Diagnostics) 6-12 h postoperatively and during the first 3 d after surgery to look for myocardial injury.
• Stroke: New focal neurologic deficit thought to be vascular in origin with signs and symptoms lasting more than 24 h.
• Pulmonary embolus: The diagnosis of pulmonary embolus required any 1 of the following:
1. A high-probability ventilation/perfusion lung scan 2. An intraluminal filling defect of the segmental or larger artery on a helical CT scan 3. An intraluminal filling defect on pulmonary angiography 4. A positive diagnostic test result for deep vein thrombosis (e.g., compression ultrasonography) and 1 of the following:
A. Nondiagnostic (i.e., low-or intermediate-probability) ventilation/perfusion lung scan B. Nondiagnostic (i.e., subsegmental defects or technically inadequate study) helical CT scan.
• Sepsis: A clinical syndrome defined by the presence of both infection and a systemic inflammatory response. Defined as a pathological process caused by the invasion of normally sterile tissue or fluid or body cavity by pathogenic or potentially pathogenic organisms. Systemic inflammatory response requires 2 or more of the following factors: core temperature > 38°C or < 36°C, heart rate > 90/min, respiratory rate > 20/min, leukocyte count > 12 × 10 as p < 0.05 for that threshold. If p ≥ 0.05, we will reject the entire variable, as it was not related to death at any dichotomization threshold. The process will continue until all candidate features have been tested. We will then join the retained features with a series of "or" statements along with "bleeding thought to be the cause of death" (which will not be subjected to the selection process). This series will form the BIMS diagnostic criteria.
Sensitivity analysis
We will repeat the analysis for objective 1 by additionally adjusting for major vascular surgery, thoracic surgery, orthopedic surgery, and major urologic or gynecologic surgery.
Objective 2: estimate prognostic value of BIMS
We will perform this analysis in all 15 109 patients with available data for MINS. Of the 15 109, 268 died within 30 days of surgery. We will categorize patients as having experienced BIMS, non-BIMS bleeding or no bleeding. We will estimate the association between BIMS and death in a shared frailty Cox proportional hazards model. BIMS will enter the model as a time-varying covariate. We will adjust the model for the same adjustment variables used in the process to select candidate features, except that in this model we will also adjust (as time-varying covariates) for MINS, sepsis, pulmonary embolism and stroke. To aid in the interpretation of the results, we will estimate the proportion of deaths potentially attributable to BIMS and all other statistically significant variables (i.e., the population attributable risk fraction) with corresponding 95% confidence intervals. We will repeat this analysis without adjustment for MINS, sepsis, pulmonary embolism or stroke because for many patients these complications may be the direct result of BIMS or its management. Comparing population attributable risk fractions adjusted and unadjusted for these complications will provide a minimum and maximum estimate of the potential independent contribution of BIMS to death.
Subgroup analyses
We will estimate the incidence and prognostic value of BIMS with respect to death in subgroups defined by age less than 75 versus 75 years or more, preoperative hemoglobin level less than 120 g/L versus 120 g/L or higher, men versus women and known cardiovascular disease versus no cardiovascular disease. We will interpret a subgroup effect as significant if the effect BIMS is associated with death in 1 of the subgroups but not in the other and if a statistical test of interaction shows a p value < 0.01. We use this stringent p value for interaction to protect against spurious findings in subgroups with few events. We additionally require that BIMS be associated with death in 1 of the subgroups but not in the other because a weaker association of BIMS with death would still satisfy the definitional requirement that BIMS be positively associated with death. 21 for any patients who were receiving dialysis preoperatively. We will model continuous variables using restricted cubic spline functions. Next, we will simplify the model through backward elimination with a p value criterion for removal of p > 0. 10 . In large samples with many events per variable tested, backward elimination produces models that can outperform competing methods. 22 We expect there will be many BIMS events given that one-third of patients experienced bleeding and 167 of them died. If there are not enough BIMS events to maintain at least 10 events per variable tested, we will combine types of surgery into larger categories (e.g., major orthopedic, major general).
We will repeat the modelling procedure in each of 1000 bootstrap samples and test each resultant version of the model on the original data, reporting model discrimination using the C-statistic and calibration employing a plot of observed versus predicted probabilities. We will report the full model as a risk-estimating equation that can be integrated into software for use on hand-held devices.
We will attempt to further simplify this model into a risk index consisting of no more than 5 equally weighted risk factors, the sum of which can stratify patients into just a few risk categories. We will report the proportion of patients who experience BIMS across the categories of this risk index, along with its C-statistic to evaluate discrimination.
Ethics approval
The research ethics board at each site approved the protocol before patient recruitment.
Interpretation
Although perioperative bleeding is common, the nature and characteristics of bleeding that increase the risk of perioperative death are unclear. We have described our methods for establishing the diagnostic criteria for BIMS and for estimating its incidence and prognostic importance. We have also described the methods for developing and testing a statistical model to predict BIMS.
We are not aware of studies that have systematically evaluated potential diagnostic criteria for BIMS. Transfusion of just 1 unit of packed erythrocytes was associated with perioperative cardiovascular events in a retrospective cohort study of hospital administrative data for 1.6 million adults. 3 This association may represent harm from transfusion or the impact of the bleeding that led to transfusion. We considered the range of hemoglobin nadir values that one might expect to contain the most discriminating threshold. In patients at high risk for cardiovascular disease who underwent surgery for hip fracture, a liberal strategy for blood transfusion (hemoglobin concentration 100 g/L) did not affect rates of death or functional outcome compared to a restrictive strategy (hemoglobin concentration < 80 g/L), 23 consistent with a recent meta-analysis of 23 trials across surgical and nonsurgical settings. 24 These data suggest that a perioperative bleeding event should not increase the risk of death unless the hemoglobin level goes below 80 g/L or perhaps 70 g/L. Finally, numerous investiga- tors have attempted to predict bleeding requiring perioperative blood transfusion in noncardiac surgery, [25] [26] [27] [28] [29] [30] [31] but those studies were small compared to our study, with samples ranging from 94 to 1875 patients, and were often limited to a single centre and type of surgery.
Limitations
The number of deaths among people who experienced a bleeding event limits the number of thresholds that we can assess for units of blood products transfused, hemoglobin nadir and hemoglobin decrement. As we assess more thresholds, we risk establishing diagnostic criteria for BIMS that are the product of statistical overfitting. Simulation studies show that, for causal inference, the risk of spurious findings is only marginally higher when we test 1 variable for every 5 events than when we test 1 variable for every 10 or more events but becomes more concerning with 4 events or fewer per variable. 32 Our sample size is also insufficient to reliably identify diagnostic criteria for BIMS in specific types of noncardiac surgery. We did not collect data at the level of individual surgeons and will not be able to adjust for the potential effects of surgeon experience on perioperative bleeding and death; our account for centre effects will serve as an imperfect surrogate. We also did not collect data regarding prior bleeding history, and such information may enhance the prediction of BIMS in future studies.
Conclusion
This study will have implications for over 200 million patients who undergo noncardiac surgery globally every year. Recognition of BIMS can direct closer monitoring and supportive care, and an estimate of the prognostic importance of BIMS can serve as an estimate of the maximum potential benefit of interventions that prevent bleeding still to be developed and tested. Prediction of BIMS can be used to enrich clinical trials and to inform the timing and appropriateness of surgery, and can guide surgical technique and perioperative care with emphasis on hemostasis.
